Why Your Knees Hurt and a Chimp's Don't: Scientists Trace Joint Pain to an Ancient Trade-off
Summarized by AI; it may make mistakes. Check important info
Summarized by AI; it may make mistakes. Check important info

Millions of people live with aching knees, stiff hips and slipped discs, while chimpanzees and gorillas stay agile into old age.
Researchers at Israel's Weizmann Institute of Science and Japan's Kyoto University now say they know why. Their study, published in Nature, finds that human cartilage contains much less glycosaminoglycans (GAGs), the molecules that, with the water they hold, make up most of cartilage.
Put simply, the cushioning in human joints may have been thinned out by evolution, and we are still paying for it.
A shortfall present from youth
The team led by molecular geneticist David Gokhman, an associate professor at the Weizmann Institute in Rehovot, worked alongside Fumitaka Inoue's laboratory in Kyoto.
The deficit was not confined to one or two joints. The reduction appeared in all eight joints studied (hips, elbows, shoulders, wrists, finger joints, and others), and in young adults in their 20s and 30s, suggesting it may be present from birth.
That matters because it suggests the problem is built into the human body rather than caused only by wear and tear.
According to the report, lower GAG levels make human joints less effective shock absorbers, which the article links to osteoarthritis, spinal disc degeneration, and herniated discs.
These conditions are uncommon in other great apes, even those living into old age.
"We have paid a biological price for becoming human," Gokhman said.
Hunting through half a million DNA differences
To find the cause, the researchers started with the genetic gap between humans and our nearest relatives.
The team compared about 500,000 single-letter DNA differences between humans and chimpanzees.
Most had little or no effect on gene function. They narrowed the search to roughly 3% that changed gene activity during skeletal development.
The tool they used was a massively parallel reporter assay, built in Inoue's lab, which tags thousands of DNA segments with barcodes to track gene activity.
The scientists also grew hybrid stem cells combining human DNA with that of a chimpanzee or a gorilla, then matured them into skeletal cells so the two genomes could be compared under identical conditions.
The result: 15,077 regulatory elements with human-specific activity, a few hundred of which were involved in the GAG pathway.
The Israeli side handled the analysis, and the full project took five years. Doctoral students Nadav Mishol (Gokhman's lab) and Yizhi Yan (Inoue's lab) led the work. Gokhman first developed the core method as a postdoctoral researcher at Stanford University.
Running faster, learning longer
Why would evolution favour weaker cartilage? The researchers offer two possible explanations.
The first is endurance running. Less cushioning may have improved running efficiency for early humans hunting over long distances.
The second is the brain. GAGs also help stabilise connections between nerve cells, so lower levels may have kept the human brain malleable longer, allowing more learning.
Gokhman pointed out that human brain development takes about 20 years, compared with about two in a wolf.
Scientists think the change built up over several million years, with the mutation probably arising quickly.
It joins a list of trade-offs that came with being human. The report mentions narrower female hips (making childbirth more painful), longer lifespans, and smaller jaws (linked to crooked teeth and chewing problems).
What it means for patients
The findings are significant because osteoarthritis affects hundreds of millions of people worldwide.
In India, where knee pain is a common complaint among older adults and squatting and cross-legged sitting put heavy daily demands on the joints, a better understanding of cartilage could eventually shape how orthopaedic specialists screen and treat patients.
Some doctors already use GAGs in treatment. Some orthopedists already inject GAGs, and early treatment might help prevent disability.
Screening is possible, though imperfect: simple genetic testing can identify some people at risk of cartilage degeneration, though better tests are needed.
A permanent fix is still a long way off. The researchers describe gene therapy for the condition as distant.
For now, the study gives a clearer answer to an old question: the ache in your knees may be part of the price our ancestors paid for longer legs and bigger brains.